The goal of this single arm pre-test post-test design study is to test the impact of providing patients with information about community-based resources to address health-related social needs and cardiometabolic health in rural African American patients. The main question it aims to answer is:
• What is the effectiveness of community resource information on patient self-efficacy to use community resources?
Participants will be given:
* A personalized "HealtheRx" resource with information about community resources related to food, housing, utility support, transportation, and crisis support. The HealtheRx is personalized for patients based on their age and zip code.
* Access to a community resource navigator for support with using the HealtheRx upon request
* 2 text messages with reminders about the HealtheRx and access to the community resource navigator
Who can participate
Age range
2 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* patient
* African American
* age 2 or older
* Have at least one cardiometabolic condition:
* Overweight (BMI greater than or equal to 25 kg/m\^2);
* Obesity (BMI greater than or equal to 30 kg/m\^2);
* ICD-9 or 10 diagnostic code for overweight or obesity
* Adult prehypertension (SBP 120 to 129 and DBP greater than 80 mmHg);
* Adult hypertension (SBP greater than or equal to130 or DBP = 80 mmHg);
* Pediatric Prehypertension (SBP or DBP greater than or equal to 90th but \<95th percentile)
* Pediatric Hypertension (SBP or DBP greater than or equal to 95th percentile);
* ICD-9 or 10 diagnostic code for hypertension
* Adult and Pediatric Prediabetes (Fasting glucose 100-125 mg/dL or OGTT 140-199 mg/dL)
* Adult and Pediatric Diabetes (FPG greater than or equal to126 mg/dL (7.0 mmol/L) or OGTT greater than or equal to 200 mg/dL (11.1mmol/L) or HgbA1C greater than or equal to 6.5);
* ICD-9 or 10 diagnostic code for diabetes, pre-diabetes or elevated glucose, or gestational diabetes;
* Adult and Pediatric Total cholesterol (\>200mg/dL; LDL \>130mg/dL; HDL \< 35 mg/dL; TG greater than or equal to150mg/dL);
* ICD-9 or 10 diagnostic code for hyperlipidemia
Exclusion Criteria:
* Unable to read, speak or understand English
* Unable to receive text message or email communications
* Living in the same household as someone already enrolled in the CRx-CVD study
* Adults with limited life expectancy (e.g., advanced cancer, end stage liver dis…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in participant self-efficacy for finding community resources